A Phase II /III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]

Tauber J, Schechter BA, Bacharach J, et al. Clin Ophthalmol. 2018;12:1921–1929. On page 1924, Efficacy end points, Conjunctival staining section, the sentence “Statistically significant reductions in the mean change from baseline in the study eye at Day 84 relative to ve...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tauber J, Schechter BA, Bacharach J, Toyos MM, Smyth-Medina R, Weiss SL, Luchs JI
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/927ca671855946069329c9e9d60abafd
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:927ca671855946069329c9e9d60abafd
record_format	dspace
spelling	oai:doaj.org-article:927ca671855946069329c9e9d60abafd2021-12-02T02:14:32ZA Phase II /III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]1177-5483https://doaj.org/article/927ca671855946069329c9e9d60abafd2018-12-01T00:00:00Zhttps://www.dovepress.com/httpswwwdovepresscomcorrigendum-a-phase-iiiii-randomized-do-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Tauber J, Schechter BA, Bacharach J, et al. Clin Ophthalmol. 2018;12:1921–1929. On page 1924, Efficacy end points, Conjunctival staining section, the sentence “Statistically significant reductions in the mean change from baseline in the study eye at Day 84 relative to vehicle were observed for both OTX-101 concentrations (P<0.01). The results by study visit are depicted in Figure 3.” should read “Statistically significant reductions in the least squares mean change from baseline in the study eye at Day 84 relative to vehicle were observed for both OTX-101 concentrations (P<0.01). The results by study visit are depicted in Figure 3.” Read the original articleTauber JSchechter BABacharach JToyos MMSmyth-Medina RWeiss SLLuchs JIDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 12, Pp 2637-2638 (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Tauber J Schechter BA Bacharach J Toyos MM Smyth-Medina R Weiss SL Luchs JI A Phase II /III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]
description	Tauber J, Schechter BA, Bacharach J, et al. Clin Ophthalmol. 2018;12:1921–1929. On page 1924, Efficacy end points, Conjunctival staining section, the sentence “Statistically significant reductions in the mean change from baseline in the study eye at Day 84 relative to vehicle were observed for both OTX-101 concentrations (P<0.01). The results by study visit are depicted in Figure 3.” should read “Statistically significant reductions in the least squares mean change from baseline in the study eye at Day 84 relative to vehicle were observed for both OTX-101 concentrations (P<0.01). The results by study visit are depicted in Figure 3.” Read the original article
format	article
author	Tauber J Schechter BA Bacharach J Toyos MM Smyth-Medina R Weiss SL Luchs JI
author_facet	Tauber J Schechter BA Bacharach J Toyos MM Smyth-Medina R Weiss SL Luchs JI
author_sort	Tauber J
title	A Phase II /III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]
title_short	A Phase II /III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]
title_full	A Phase II /III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]
title_fullStr	A Phase II /III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]
title_full_unstemmed	A Phase II /III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]
title_sort	phase ii /iii, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of otx-101 in the treatment of dry eye disease [corrigendum]
publisher	Dove Medical Press
publishDate	2018
url	https://doaj.org/article/927ca671855946069329c9e9d60abafd
work_keys_str_mv	AT tauberj aphaseiiiiirandomizeddoublemaskedvehiclecontrolleddoserangingstudyofthesafetyandefficacyofotx101inthetreatmentofdryeyediseasecorrigendum AT schechterba aphaseiiiiirandomizeddoublemaskedvehiclecontrolleddoserangingstudyofthesafetyandefficacyofotx101inthetreatmentofdryeyediseasecorrigendum AT bacharachj aphaseiiiiirandomizeddoublemaskedvehiclecontrolleddoserangingstudyofthesafetyandefficacyofotx101inthetreatmentofdryeyediseasecorrigendum AT toyosmm aphaseiiiiirandomizeddoublemaskedvehiclecontrolleddoserangingstudyofthesafetyandefficacyofotx101inthetreatmentofdryeyediseasecorrigendum AT smythmedinar aphaseiiiiirandomizeddoublemaskedvehiclecontrolleddoserangingstudyofthesafetyandefficacyofotx101inthetreatmentofdryeyediseasecorrigendum AT weisssl aphaseiiiiirandomizeddoublemaskedvehiclecontrolleddoserangingstudyofthesafetyandefficacyofotx101inthetreatmentofdryeyediseasecorrigendum AT luchsji aphaseiiiiirandomizeddoublemaskedvehiclecontrolleddoserangingstudyofthesafetyandefficacyofotx101inthetreatmentofdryeyediseasecorrigendum AT tauberj phaseiiiiirandomizeddoublemaskedvehiclecontrolleddoserangingstudyofthesafetyandefficacyofotx101inthetreatmentofdryeyediseasecorrigendum AT schechterba phaseiiiiirandomizeddoublemaskedvehiclecontrolleddoserangingstudyofthesafetyandefficacyofotx101inthetreatmentofdryeyediseasecorrigendum AT bacharachj phaseiiiiirandomizeddoublemaskedvehiclecontrolleddoserangingstudyofthesafetyandefficacyofotx101inthetreatmentofdryeyediseasecorrigendum AT toyosmm phaseiiiiirandomizeddoublemaskedvehiclecontrolleddoserangingstudyofthesafetyandefficacyofotx101inthetreatmentofdryeyediseasecorrigendum AT smythmedinar phaseiiiiirandomizeddoublemaskedvehiclecontrolleddoserangingstudyofthesafetyandefficacyofotx101inthetreatmentofdryeyediseasecorrigendum AT weisssl phaseiiiiirandomizeddoublemaskedvehiclecontrolleddoserangingstudyofthesafetyandefficacyofotx101inthetreatmentofdryeyediseasecorrigendum AT luchsji phaseiiiiirandomizeddoublemaskedvehiclecontrolleddoserangingstudyofthesafetyandefficacyofotx101inthetreatmentofdryeyediseasecorrigendum
_version_	1718402609972248576

A Phase II /III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]

Ejemplares similares